(0.31%) 5 115.64 points
(0.24%) 38 331 points
(0.35%) 15 983 points
(-1.09%) $82.94
(5.10%) $2.02
(0.18%) $2 351.50
(0.42%) $27.65
(3.76%) $956.75
(-0.25%) $0.932
(-0.34%) $10.99
(-0.56%) $0.796
(1.65%) $93.39
-0.50% ¥ 996.00
Live Chart Being Loaded With Signals
DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters...
Stats | |
---|---|
Tagesvolumen | 56 600.00 |
Durchschnittsvolumen | 11 800.00 |
Marktkapitalisierung | 10.40B |
EPS | ¥0 ( 2024-01-30 ) |
Nächstes Ertragsdatum | ( ¥0 ) 2024-05-13 |
Last Dividend | ¥30.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 26.11 |
ATR14 | ¥1.661 (0.17%) |
Volumen Korrelation
DVx Inc. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
DVx Inc. Korrelation - Währung/Rohstoff
DVx Inc. Finanzdaten
Annual | 2022 |
Umsatz: | ¥47.48B |
Bruttogewinn: | ¥5.46B (11.49 %) |
EPS: | ¥90.21 |
FY | 2022 |
Umsatz: | ¥47.48B |
Bruttogewinn: | ¥5.46B (11.49 %) |
EPS: | ¥90.21 |
FY | 2022 |
Umsatz: | ¥45.50B |
Bruttogewinn: | ¥5.34B (11.73 %) |
EPS: | ¥83.56 |
FY | 2021 |
Umsatz: | ¥41.01B |
Bruttogewinn: | ¥4.96B (12.09 %) |
EPS: | ¥55.60 |
Financial Reports:
No articles found.
DVx Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥5.00 | 2010-03-29 |
Last Dividend | ¥30.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | ¥229.63 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.23 | -- |
Div. Sustainability Score | 6.93 | |
Div.Growth Potential Score | 3.61 | |
Div. Directional Score | 5.27 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6638.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
5965.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
4662.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
3902.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3134.T | Ex Dividend Junior | 2024-04-26 | Annually | 0 | 0.00% | |
2004.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8999.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
8550.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7872.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7013.T | No Dividend Player | 2023-09-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00861 | 1.500 | 9.83 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0175 | 1.200 | 9.42 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0432 | 1.500 | -0.631 | -0.947 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.617 | 0.800 | 6.92 | 5.53 | [1 - 3] |
quickRatioTTM | 1.439 | 0.800 | 6.24 | 4.99 | [0.8 - 2.5] |
cashRatioTTM | 0.563 | 1.500 | 7.98 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 3 364.07 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.107 | 1.000 | -1.548 | -1.548 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0183 | 1.000 | -1.634 | -1.634 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 2.03 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 6.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 26.16 | 1.000 | 7.46 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0432 | 2.50 | -0.406 | -0.947 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.02 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 82.27 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.833 | 1.500 | 1.114 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0186 | 1.000 | -2.03 | 0 | [0.1 - 0.5] |
Total Score | 3.61 |
DVx Inc.
DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.